You are here

acromegaly

FDA declines to approve Camurus' rare hormone disorder drug

Reuters

Tue, 10/22/24 - 11:24 am

Chiasma secures FDA approval for acromegaly pill Mycapssa years after near-catastrophic rejection

Fierce Pharma

Mon, 06/29/20 - 06:20 pm

Upcoming events – Phase III data for Chiasma and Novartis

EP Vantage

Fri, 05/17/19 - 07:23 pm

clinical trials

multiple sclerosis

Chiasma CEO says company may challenge FDA over rare-disease drug rejection

Bizjournals.com

Thu, 05/12/16 - 09:46 am

Chiasma's Acromegaly Drug Headed for FDA Rejection, Investor Says

TheStreet.com

Thu, 04/14/16 - 10:08 am

2 FDA Actions To Watch In April

Seeking Alpha

Mon, 03/28/16 - 09:12 pm

Sarepta Therapeutics

Duchenne Muscular Dystrophy

With Roche out the door, Chiasma is raising $56M to go it alone

Fierce Biotech

Fri, 01/2/15 - 10:50 am

FDA Okays Novartis AG’s (NVS) Signifor LAR To Treat Acromegaly

Bidness Etc.

Wed, 12/17/14 - 08:32 am

Novartis picks up its development option in $700M rare-disease pact

Fierce Biotech

Tue, 09/10/13 - 11:27 am